Cansortium Inc.

Equities

TIUM.U

CA13809L1094

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange Other stock markets 11:07:14 2024-05-28 am EDT			5-day change	1st Jan Change
0.16 ^USD	0.00%		-5.88%	+77.78%

May. 16	Cansortium Inc. Announces Chief Financial Officer Changes	CI
Apr. 30	Cansortium Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Cansortium Inc. Provides Consolidated Financial Outlook for 2021

May 03, 2021 at 06:41 pm EDT

Cansortium Inc. provided consolidated financial Outlook for 2021. The Company is projecting consolidated revenue of approximately $90 million to $100 million for 2021. With a strong foundation of assets and people in place, the company looks forward to delivering on robust growth and profitability outlook for 2021.

Latest news about Cansortium Inc.

Cansortium Inc. Announces Chief Financial Officer Changes	May. 16	CI
Cansortium Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Transcript : Cansortium Inc., Q4 2023 Earnings Call, Apr 29, 2024	Apr. 29
Cansortium Inc. Opens 34th Medical Cannabis Dispensary in Cocoa, Florida	Jan. 22	CI
Cansortium Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Transcript : Cansortium Inc., Q3 2023 Earnings Call, Nov 29, 2023	Nov. 29
Cansortium Seeks M&A	23-08-28	CI
Transcript : Cansortium Inc., Q2 2023 Earnings Call, Aug 28, 2023	23-08-28
Cansortium Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-27	CI
Cansortium Inc. Opens Jacksonville Cassat, a Medical Cannabis Dispensary in Florida	23-08-23	CI
Cansortium Inc. Announces Board Changes	23-07-21	CI
Cansortium Inc. Announces the Opening of Its 32nd Medical Cannabis Dispensary in Florida and 35th Retail Location Nationwide	23-07-13	CI
Cansortium Outlines Shares for Debt Transaction	23-06-02	MT
Transcript : Cansortium Inc., Q1 2023 Earnings Call, May 31, 2023	23-05-31
Cansortium Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Cansortium Inc. Announces the Launch of Its New Cannabis-Infused Dark Chocolate Bar in Florida	23-05-24	CI
Cansortium Inc. Moves U.S. Headquarters to Tampa, Florida	23-05-16	CI
Cansortium Inc. Opens 34Th Nationwide and 31St Medical Cannabis Dispensary in Pensacola, Florida	23-05-11	CI
Transcript : Cansortium Inc., Q4 2022 Earnings Call, May 01, 2023	23-05-01
Cansortium Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-04-30	CI
Cansortium Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-30	CI
Cansortium Inc. Announces Grand Opening of Its 30Th Medical Cannabis Dispensary in Florida and 33Rd Nationwide, Located At 763 Atlantic Blvd	23-03-15	CI
Cansortium Inc. Names CFO	23-03-14	MT
Cansortium Inc. Announces Chief Financial Officer Changes	23-03-14	CI
Cansortium Inc. announced that it has received $3 million in funding from Sage Investing Ltd and another investor	23-02-27	CI

Chart Cansortium Inc.

Duration

Period

More charts

Company Profile

Cansortium Inc. is a vertically integrated cannabis company with licenses and operations in Florida, Pennsylvania and Texas. The Company operates under the private label, Fluent. The Company, through its subsidiaries, is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The Companyâs medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges and edibles and accessories. The Companyâs subsidiaries include Cansortium Holdings LLC, Cansortium Pennsylvania, LLC, Cansortium Puerto Rico, LLC, Cansortium Texas, LLC, Cansortium Canada Holdings Inc., Fluent Servicing, LLC, Cansortium Florida, LLC., Spirit Lake Road Nursery, LLC, Harvest Park Lot 9 Investors LLC, Fluent Hemp LLC and Cansortium Michigan LLC.

Sector

Healthcare Facilities & Services

Calendar

2024-05-28 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.16 USD

Average target price

0.7 USD

Spread / Average Target

+337.50%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Farming

	1st Jan change	Capi.
CANSORTIUM INC.	+77.78%	47.92M
CRUCIAL INNOVATIONS CORP.	-.--%	339M
AYR WELLNESS INC.	+23.87%	244M
ASCEND WELLNESS HOLDINGS, INC.	+8.25%	223M
ORGANIGRAM HOLDINGS INC.	+40.70%	183M
INTERCURE LTD.	+152.43%	149M
JUSHI HOLDINGS INC.	+33.76%	121M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
THE CANNABIST COMPANY HOLDINGS INC.	-44.42%	114M
4FRONT VENTURES CORP.	-7.69%	80.53M

Medical Farming